Brief: Firebrick Pharma Posts HY Loss After Tax Attributable A$3.1 Mln
17/02/2023 05:57
Feb 17 (Reuters) - Firebrick Pharma Ltd FRE.AX :
* HY LOSS AFTER TAX ATTRIBUTABLE A$3.1 MILLION VERSUS LOSS
A$1.5
MILLION
Source text for Eikon: ID:nASX8Q4wBS
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement